NCT01434485已完成不适用
Nexium Capsules Clinical Experience Investigation
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 3,691
- 试验地点
- 1
- 主要终点
- Number of Adverse Drug Reactions
研究概览
简要总结
The purpose of this study is to confirm the safety profile / factors which impact safety and efficacy of Nexium capsules in daily clinical usage for the patients who have been prescribed Nexium for "gastric ulcer", "duodenal ulcer", "anastomotic ulcer", "reflux oesophagitis", "non-erosive reflux disease", or "Zollinger-Ellison syndrome"
详细描述
Nexium capsules Clinical Experience Investigation
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated with Nexium for the first time due to gastric ulcer, duodenal ulcer, anastomotic ulcer, reflux oesophagitis, non-erosive reflux disease, Zollinger-Ellison syndrome.
排除标准
- 未提供
结局指标
主要结局
Number of Adverse Drug Reactions
时间窗: Patients with non-erosive reflux disease: 4 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Nexium Capsules Helicobacter Pylori Specific Clinical Experience InvestigationGastric Mucosa-associated Lymphoid Tissue (MALT)Lymphoma Idiopathic Thrombocytopenic PurpuraEarly Gastric CancerGastric UlcerDuodenal UlcerNCT01435525AstraZeneca369
已完成
不适用
Nexium Capsules RE Maintenance Specific Clinical Experience InvestigationRepeatedly Recurring EsophagitisRelapsing Reflux EsophagitisNCT01562639AstraZeneca647
已完成
不适用
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience InvestigationGastric UlcerDuodenal UlcerNCT01562600AstraZeneca1,634
已完成
不适用
Nexium Capsules LDA Specific Clinical Experience InvestigationGastric UlcerDuodenal UlcerNCT01729182AstraZeneca2,363
已完成
不适用
Nexium Capsules S-CEI for Justification of Esomeprazole in Acid Related Disease for Reflux Symptom Healing Based on Patient Clinical OutcomesReflux EsophagitisNCT02477475AstraZeneca1,595